Literature DB >> 33893172

Natural killer cell receptors regulate responses of HLA-E-restricted T cells.

Lucy C Sullivan1,2, Thi H O Nguyen3, Christopher M Harpur3, Sanda Stankovic3, Abbie R Kanagarajah3, Marios Koutsakos3, Philippa M Saunders3, Zhangying Cai3, James A Gray3, Jacqueline M L Widjaja3, Jie Lin3, Gabriella Pietra4,5, Maria Cristina Mingari4,5,6, Lorenzo Moretta7, Jerome Samir8, Fabio Luciani8, Glen P Westall2, Karl J Malmberg9,10,11, Katherine Kedzierska3, Andrew G Brooks1.   

Abstract

Human cytomegalovirus (CMV) infection can stimulate robust human leukocyte antigen (HLA)-E-restricted CD8+ T cell responses. These T cells recognize a peptide from UL40, which differs by as little as a single methyl group from self-peptides that also bind HLA-E, challenging their capacity to avoid self-reactivity. Unexpectedly, we showed that the UL40/HLA-E T cell receptor (TCR) repertoire included TCRs that had high affinities for HLA-E/self-peptide. However, paradoxically, lower cytokine responses were observed from UL40/HLA-E T cells bearing TCRs with high affinity for HLA-E. RNA sequencing and flow cytometric analysis revealed that these T cells were marked by the expression of inhibitory natural killer cell receptors (NKRs) KIR2DL1 and KIR2DL2/L3. On the other hand, UL40/HLA-E T cells bearing lower-affinity TCRs expressed the activating receptor NKG2C. Activation of T cells bearing higher-affinity TCRs was regulated by the interaction between KIR2D receptors and HLA-C. These findings identify a role for NKR signaling in regulating self/non-self discrimination by HLA-E-restricted T cells, allowing for antiviral responses while avoiding contemporaneous self-reactivity.
Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33893172     DOI: 10.1126/sciimmunol.abe9057

Source DB:  PubMed          Journal:  Sci Immunol        ISSN: 2470-9468


  5 in total

1.  Human cytomegalovirus expands a CD8+ T cell population with loss of BCL11B expression and gain of NK cell identity.

Authors:  Rosa Sottile; M Kazim Panjwani; Colleen M Lau; Anthony F Daniyan; Kento Tanaka; Juliet N Barker; Renier J Brentjens; Joseph C Sun; Jean-Benoît Le Luduec; Katharine C Hsu
Journal:  Sci Immunol       Date:  2021-09-24

Review 2.  Narrative review of the relationship between the maternal-fetal interface immune tolerance and the onset of preeclampsia.

Authors:  Fangyuan Luo; Jun Yue; Lingling Li; Jie Mei; Xinghui Liu; Yu Huang
Journal:  Ann Transl Med       Date:  2022-06

3.  Identification and Characterization of Antigen-Specific CD8+ T Cells Using Surface-Trapped TNF-α and Single-Cell Sequencing.

Authors:  Shaheed Abdulhaqq; Abigail B Ventura; Jason S Reed; Arman A Bashirova; Katherine B Bateman; Eric McDonald; Helen L Wu; Justin M Greene; John B Schell; David Morrow; Karin Wisskirchen; Jeffrey N Martin; Steven G Deeks; Mary Carrington; Ulrike Protzer; Klaus Früh; Scott G Hansen; Louis J Picker; Jonah B Sacha; Benjamin N Bimber
Journal:  J Immunol       Date:  2021-11-22       Impact factor: 5.426

Review 4.  Antigen presentation by MHC-E: a putative target for vaccination?

Authors:  Linda Voogd; Paula Ruibal; Tom H M Ottenhoff; Simone A Joosten
Journal:  Trends Immunol       Date:  2022-03-31       Impact factor: 19.709

5.  Deep Phenotypic Analysis of Blood and Lymphoid T and NK Cells From HIV+ Controllers and ART-Suppressed Individuals.

Authors:  Ashley F George; Xiaoyu Luo; Jason Neidleman; Rebecca Hoh; Poonam Vohra; Reuben Thomas; Min-Gyoung Shin; Madeline J Lee; Catherine A Blish; Steven G Deeks; Warner C Greene; Sulggi A Lee; Nadia R Roan
Journal:  Front Immunol       Date:  2022-01-27       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.